(Q34338919)

1 August 2017

1 reference

title

P53 mutations in thyroid carcinoma: tidings from an old foe. (English)

1 reference

1 August 2017

1 reference

Farid NR

1

1 reference

1 August 2017

publication date

1 July 2001

1 reference

Journal of Endocrinological Investigation

1 August 2017

published in

1 reference

1 August 2017

volume

24

1 reference

1 August 2017

issue

7

1 reference

1 August 2017

page(s)

536-545

1 reference

1 August 2017

cites work

Surfing the p53 network

1 reference

https://api.crossref.org/works/10.1007%2FBF03343889

New approaches to understanding p53 gene tumor mutation spectra

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03343889

Functional collaboration between different cyclin-dependent kinase inhibitors suppresses tumor growth with distinct tissue specificity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03343889

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03343889

p53, the cellular gatekeeper for growth and division

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03343889

The DNA damage response: putting checkpoints in perspective

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03343889

Reprimo, a new candidate mediator of the p53-mediated cell cycle arrest at the G2 phase

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03343889

14-3-3Sigma is required to prevent mitotic catastrophe after DNA damage

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03343889

Association of the cyclin-dependent kinases and 14-3-3 sigma negatively regulates cell cycle progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03343889

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03343889

Evidence of gene deletion of p21 (WAF1/CIP1), a cyclin-dependent protein kinase inhibitor, in thyroid carcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03343889

The expression of the MDM2 gene, a p53 binding protein, in thyroid carcinogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03343889

Molecular pathogenesis of thyroid cancer: the significance of oncogenes, tumor suppressor genes, and genomic instability

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03343889

p53 gene mutations associated with anaplastic transformation of human thyroid carcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03343889

Genetic alterations in thyroid tumor progression: association with p53 gene mutations.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03343889

High prevalence of mutations of the p53 gene in poorly differentiated human thyroid carcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03343889

Low frequency of p53 mutations in human thyroid tumours; p53 and Ras mutation in two out of fifty-six thyroid tumours

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03343889

p53 mutations in childhood thyroid tumours from Belarus and in thyroid tumours without radiation history.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03343889

How many mutations does it take to make a tumor?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03343889

Genetic instabilities in human cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03343889

Explaining the high mutation rates of cancer cells to drug and multidrug resistance by chromosome reassortments that are catalyzed by aneuploidy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03343889

Strand asymmetry of CpG transitions as indicator of G1 phase-dependent origin of multiple tumorigenic p53 mutations in stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03343889

Crystal structure of a p53 tumor suppressor-DNA complex: understanding tumorigenic mutations

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03343889

Genetic reconstruction of individual colorectal tumor histories

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03343889

p53 mutations in tumors derived from irradiated human thyroid epithelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03343889

Mutagenesis by 8-oxoguanine: an enemy within

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03343889

Increased p53 mutation load in nontumorous human liver of wilson disease and hemochromatosis: oxyradical overload diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03343889

Genetic selection of intragenic suppressor mutations that reverse the effect of common p53 cancer mutations

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03343889

Hot-spot mutants of p53 core domain evince characteristic local structural changes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03343889

Constitutive activation of gene expression by thyroid hormone receptor results from reversal of p53-mediated repression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03343889

Tumor suppressor p53 is a negative regulator in thyroid hormone receptor signaling pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03343889

Regulation of the mdm2 oncogene by thyroid hormone receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03343889

Geographic variation of p53 mutational profile in nonmalignant human liver

21 January 2018

1 reference

12 December 2020

Mutations in the p53 tumor suppressor gene: clues to cancer etiology and molecular pathogenesis

1 reference

12 December 2020

Frequent loss of heterozygosity on chromosomes 3p and 17p without VHL or p53 mutations suggests involvement of unidentified tumor suppressor genes in follicular thyroid carcinoma

1 reference

12 December 2020

Gene p53 mutations are restricted to poorly differentiated and undifferentiated carcinomas of the thyroid gland

1 reference

12 December 2020

p53 gene mutations in radiation-induced thyroid cancer.

1 reference

12 December 2020

Molecular alterations involving p53 codons 167 and 183 in papillary thyroid carcinomas from chernobyl-contaminated regions of belarus

1 reference

12 December 2020

Anaplastic changes associated with p53 gene mutation in differentiated thyroid carcinoma after insufficient radioactive iodine (131I) therapy

1 reference

12 December 2020

p53 mutations in all stages of thyroid carcinomas.

1 reference

12 December 2020

Silent and multiple mutations in p53 and the question of the hypermutability of tumors

1 reference

12 December 2020

Unique association of p53 mutations with undifferentiated but not with differentiated carcinomas of the thyroid gland

1 reference

12 December 2020

Prevalences of Gs alpha, ras, p53 mutations and ret/PTC rearrangement in differentiated thyroid tumours in a Korean population

1 reference

12 December 2020

Stepwise participation of p53 gene mutation during dedifferentiation of human thyroid carcinomas

1 reference

12 December 2020

Mutations of p53 in thyroid carcinoma with an insular component

1 reference

12 December 2020

The risks and benefits of radioiodine therapy for thyroid carcinoma remain somewhat undifferentiated

1 reference

12 December 2020

Alterations of p53 and expression of WAF1/p21 in human thyroid tumors

1 reference

12 December 2020

Methylation of the oestrogen receptor CpG island links ageing and neoplasia in human colon

1 reference

12 December 2020

Microsatellite instability: marker of a mutator phenotype in cancer.

1 reference

12 December 2020

Mutations in the p53 tumour suppressor gene in thyroid tumours of children from areas contaminated by the Chernobyl accident

1 reference

12 December 2020

De-mystifying the mechanism(s) of maspin

1 reference

12 December 2020

Molecular basis of thyroid cancer

1 reference

12 December 2020

Pharmacological rescue of mutant p53 conformation and function

1 reference

12 December 2020

Prevalence of mutations of ras and p53 in benign and malignant thyroid tumors from children exposed to radiation after the Chernobyl nuclear accident.

1 reference

12 December 2020

Thyroid carcinoma is characterized by genomic instability: evidence from p53 mutations

1 reference

12 December 2020

Aging and DNA methylation in colorectal mucosa and cancer

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF03343889

1 reference

Dimensions Publication ID

1 August 2017

1034158442

0 references

1 reference